Joseph Mugaanyi
Overview
Explore the profile of Joseph Mugaanyi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mugaanyi J, Dai L, Lu C, Mao S, Huang J, Lu C
J Clin Med
. 2023 Jan;
12(1).
PMID: 36615037
Background: The gap between the demand and supply of donor livers is still a considerable challenge. Since static cold storage is not sufficient in marginal livers, machine perfusion is being...
12.
Mugaanyi J, Lu C, Huang J, Lu C
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551588
Undifferentiated pancreatic carcinomas are rare malignant tumors of the pancreas that are very aggressive and challenging to diagnose. The WHO categorizes them into undifferentiated osteoclast-like giant cell, sarcomatoid, and rhabdoid...
13.
Mugaanyi J, Tong J, Lu C, Mao S, Huang J, Lu C
Transpl Immunol
. 2022 Dec;
76:101767.
PMID: 36470573
Objective: To determine the risk factors for acute rejection in liver transplantation and its impact on the outcomes of the recipients. Methods: Clinicopathological data of 290 patients who underwent liver...
14.
Dai L, Mugaanyi J, Zhang T, Tong J, Cai X, Lu C, et al.
PLoS One
. 2022 Sep;
17(9):e0274823.
PMID: 36126083
SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers...
15.
Li Z, Liu Y, Fu J, Mugaanyi J, Yan J, Lu C, et al.
Front Oncol
. 2022 Sep;
12:961939.
PMID: 36091112
Objective: The aim of this study is to determine the clinical efficacy of bile-derived liquid biopsy compared with plasma and tumor tissue biopsy in patients with biliary tract carcinoma (BTC)....
16.
Dai L, Mugaanyi J, Cai X, Dong M, Lu C, Lu C
Sci Rep
. 2022 Aug;
12(1):13639.
PMID: 35948625
Matrix metalloproteinase 1 (MMP1) encodes endopeptidases associated with degradation of multiple components of the extracellular matrix. This function has increasingly been considered to play a major proteolysis role in tumor...
17.
Dai L, Mugaanyi J, Cai X, Lu C, Lu C
Sci Rep
. 2022 Jul;
12(1):11944.
PMID: 35831362
Pancreatic adenocarcinoma (PAAD) has high mortality and a very poor prognosis. Both surgery and chemotherapy have a suboptimal therapeutic effect, and this caused a need to find new approaches such...
18.
Mao S, Yu X, Sun J, Yang Y, Shan Y, Sun J, et al.
BMC Cancer
. 2022 Mar;
22(1):249.
PMID: 35255845
Background: Inflammation plays a significant role in tumour development, progression, and metastasis. In this study, we focused on comparing the predictive potential of inflammatory markers for overall survival (OS), recurrence-free...
19.
Dai L, Cai X, Mugaanyi J, Liu Y, Mao S, Lu C, et al.
Sci Rep
. 2021 Oct;
11(1):19711.
PMID: 34611195
Immune checkpoint inhibitor therapy has shown promising results in patients with unresectable hepatocellular carcinoma. This study aimed to evaluate the effectiveness and safety of sintilimab, a programmed cell death protein-1...
20.
Mao S, Yu X, Yang Y, Shan Y, Mugaanyi J, Wu S, et al.
Sci Rep
. 2021 Oct;
11(1):20047.
PMID: 34608256
No abstract available.